Profile | GDS4284 / 222848_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 623.365 | 67 |
GSM687648 | Patient 402 control | 1251.96 | 77 |
GSM687653 | Patient 403 control | 963.199 | 74 |
GSM687658 | Patient 404 control | 878.957 | 72 |
GSM687663 | Patient 411 control | 296.062 | 55 |
GSM687668 | Patient 422 control | 452.019 | 62 |
GSM687673 | Patient 424 control | 448.252 | 61 |
GSM687678 | Patient 425 control | 697.531 | 68 |
GSM687683 | Patient 427 control | 877.746 | 71 |
GSM687688 | Patient 428 control | 586.289 | 66 |
GSM687695 | Patient 441 control | 382.959 | 55 |
GSM687699 | Patient 443 control | 492.418 | 62 |
GSM687704 | Patient 444 control | 356.759 | 59 |
GSM687707 | Patient 448 control | 988.473 | 74 |
GSM687712 | Patient 449 control | 635.286 | 67 |
GSM687719 | Patient 450 control | 751.905 | 69 |
GSM687724 | Patient 451 control | 721.506 | 69 |
GSM687728 | Patient 452 control | 699.461 | 69 |
GSM687646 | Patient 401 treated 24h | 575.264 | 65 |
GSM687649 | Patient 402 treated 24h | 1228.61 | 77 |
GSM687665 | Patient 411 treated 24h | 483.348 | 62 |
GSM687651 | Patient 402 treated 4 weeks | 678.644 | 68 |
GSM687667 | Patient 411 treated 4 weeks | 540.355 | 64 |
GSM687670 | Patient 422 treated 24h | 598.231 | 66 |
GSM687671 | Patient 422 treated 4 weeks | 459.807 | 62 |
GSM687654 | Patient 403 treated 24h | 903.518 | 73 |
GSM687675 | Patient 424 treated 24h | 599.454 | 66 |
GSM687685 | Patient 427 treated 24h | 644.078 | 67 |
GSM687656 | Patient 403 treated 4 weeks | 797.132 | 71 |
GSM687677 | Patient 424 treated 4 weeks | 374.774 | 59 |
GSM687687 | Patient 427 treated 4 weeks | 992.323 | 73 |
GSM687692 | Patient 428 treated 4h | 989.155 | 74 |
GSM687716 | Patient 449 treated 4h | 574.034 | 66 |
GSM687722 | Patient 450 treated 4h | 663.55 | 67 |
GSM687680 | Patient 425 treated 24h | 760.93 | 70 |
GSM687690 | Patient 428 treated 24h | 1054.72 | 75 |
GSM687700 | Patient 443 treated 24h | 500.682 | 61 |
GSM687705 | Patient 444 treated 24h | 335.348 | 59 |
GSM687714 | Patient 449 treated 24h | 634.31 | 68 |
GSM687721 | Patient 450 treated 24h | 644.964 | 67 |
GSM687682 | Patient 425 treated 4 weeks | 641.437 | 68 |
GSM687694 | Patient 428 treated 4 weeks | 675.336 | 68 |
GSM687702 | Patient 443 treated 4 weeks | 764.112 | 69 |
GSM687718 | Patient 449 treated 4 weeks | 549.31 | 66 |
GSM687723 | Patient 450 treated 4 weeks | 641.611 | 67 |
GSM687661 | Patient 404 treated 4h | 1231.95 | 77 |
GSM687710 | Patient 448 treated 4h | 948.516 | 74 |
GSM687726 | Patient 451 treated 4h | 786.972 | 70 |
GSM687730 | Patient 452 treated 4h | 248.693 | 37 |
GSM687660 | Patient 404 treated 24h | 548.533 | 66 |
GSM687697 | Patient 441 treated 24h | 609.725 | 66 |
GSM687709 | Patient 448 treated 24h | 1189.55 | 77 |
GSM687725 | Patient 451 treated 24h | 777.55 | 70 |
GSM687729 | Patient 452 treated 24h | 279.443 | 50 |
GSM687727 | Patient 451 treated 4 weeks | 508.747 | 63 |
GSM687731 | Patient 452 treated 4 weeks | 635.158 | 67 |